Tag: Ocugen

The biotech sector has a standout performer as Ocugen's stock demonstrates remarkable momentum, reaching fresh milestones while many peers struggle. ...

The biotechnology firm Ocugen has captured market attention with a remarkable performance surge, gaining more than 26% over a two-week ...

Ocugen is executing a strategic campaign to position itself at the forefront of gene therapy. The company has announced a ...

A surge in bullish options trading has drawn significant attention to biotech firm Ocugen, with market participants taking substantial positions ...

A single research report from Lucid Capital sent Ocugen shares skyrocketing on Tuesday, with the biopharmaceutical company experiencing a dramatic ...

Biotechnology firm Ocugen has announced a significant licensing agreement that marks its first regional partnership for experimental therapy OCU400. The ...

The biotech sector is witnessing a classic battle of opposing narratives play out in Ocugen shares. Conflicting developments from a ...

Biotechnology firm Ocugen confronts a significant strategic challenge following the abrupt termination of a major merger agreement. The collapse of ...

Investors in Ocugen experienced a day of conflicting signals this Friday. The biotech firm's stock declined by more than 4%, ...

While Ocugen faces immediate pressure from a collapsed acquisition deal, the biotech firm is simultaneously receiving strong endorsements from two ...